Circulating matrix gamma-carboxyglutamate protein (MGP) species are refractory to vitamin K treatment in a new case of Keutel syndrome

E. C. M. Cranenburg, K. Y. van Spaendonck-Zwarts, Luisa Bonafe, L. Mittaz Crettol, L. A. Rodiger, F. G. Dikkers, Anthonie J. van Essen, Andrea Superti-Furga, E. Alexandrakis, C. Vermeer, L. J. Schurgers, Gozewijn D. Laverman

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1225-1235
JournalJournal of Thrombosis and Haemostasis
Volume9
Issue number6
DOIs
Publication statusPublished - Jun 2011

Keywords

  • arterial calcification
  • Keutel syndrome
  • matrix Gla protein
  • osteopontin
  • vitamin K

Cite this

Cranenburg, E. C. M., van Spaendonck-Zwarts, K. Y., Bonafe, L., Crettol, L. M., Rodiger, L. A., Dikkers, F. G., van Essen, A. J., Superti-Furga, A., Alexandrakis, E., Vermeer, C., Schurgers, L. J., & Laverman, G. D. (2011). Circulating matrix gamma-carboxyglutamate protein (MGP) species are refractory to vitamin K treatment in a new case of Keutel syndrome. Journal of Thrombosis and Haemostasis, 9(6), 1225-1235. https://doi.org/10.1111/j.1538-7836.2011.04263.x